October 31, 2022 1:30pm - 3:30pm ET
Activity Overview
This activity combines a core curriculum developed by a steering committee of renowned experts in the medical management of acute lymphoblastic leukemia (ALL) with real-world cases that challenge learners to reflect on the application of clinical evidence to their own practices. The Reflective Case-Based Oncology Collective™ brings clinical experts and community oncologists together virtually to consider the most appropriate and efficacious incorporation of new and available agents into clinical management of patients with ALL.
Target Audience
The live activity series is directed toward medical oncologists, hematologist/oncologists, nurse practitioners, and physician assistants who treat patients with ALL. Pathologists, fellows, nurses, pharmacists, and other health care professionals interested in the management of ALL are also invited to participate in the online activity.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Demonstrate the ability to utilize MRD assessment in the management of patients with ALL
- Integrate current novel chemotherapy-free strategies into individualized treatment plans for the management of patients with relapsed or refractory ALL
- Discuss evolving strategies and novel combinations in the management of patients with relapsed or refractory ALL
- Implement proactive strategies to monitor, mitigate, and manage treatment-associated toxicities in patients with relapsed or refractory ALL being managed with novel approaches to care
Benefits of Attending
- Direct interaction with world-renowned experts in ALL management
- Hear varied perspectives on how to manage your most challenging real-world cases
- Learn ways to monitor for and mitigate adverse events in your patients with ALL
- Incorporate recent clinical trial data into your clinical practice with confidence
